Effect of Sasa quelpaertensis Nakai extract consumption on cholesterol levels

Effect of Sasa quelpaertensis Nakai extract consumption on cholesterol levels in mildly hypercholesterolemic adults

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000651

Enrollment

Registered

2013-02-01

Start date

2012-12-04

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : consumption of placebo or Sasa quelpaertensis Nakai extract(1g or 2g) for 4 weeks.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Voluntarily agree to participate and signed in informed consent form 2) Adults aged over 20 years 3) Plasma total cholesterol levels = 200mg/dl and < 250mgl/dl

Exclusion criteria

Exclusion criteria: 1) Continuous consumption of drug or dietary supplement that affect lipid metabolism within 4 weeks before the first visit (statin, fibrate, beta-blocker, etc) 2) Following diseases: ? Myocardial infarction, stroke, uncontrolled hypertension (= 140/90mmHg) ? Diabetes ? Liver failure(AST, ALT rose more than 2.5 times the upper limit of normal) ? Renal impairment (Creatinine = 1.4mg/dl) ? Hyperthyroidism and hypothyroidism ? Malignant tumors 3) Familial hypercholesterolemia 4) BMI: <18kg/m2 and = 30kg/m2 5) Participation in another clinical trial within 4 weeks of first visit 6) Alcoholic 7) Any condition that the principal investigator belives may put the subjects at undue risk

Design outcomes

Primary

Measure	Time frame
Blood lipid profile (total cholesterol, LDL-cholesterol, HDL-cholesterol, VLDL-cholesterol)	—

Secondary

Measure	Time frame
Inflammatory biomarker (CRP, TNF-a)	—

Countries

Korea, Republic of

Contacts

Public ContactHyaYoun Park

The Catholic University of Korea Catholic Medical Center

Outcome results